Pharmacists in Emporia, VA Accepting Medicare

9 Pharmacists found. Showing 1 - 9

Dr. Luke Whitehead, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 306 W Atlantic St, Emporia, VA 23847 Phone: 434-348-3181

Constance Whittemore Poland Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 303 Market Dr, Emporia, VA 23847 Phone: 434-336-9310

Mr. John Pearman Jones, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 306a Weaver Ave, Emporia, VA 23847 Phone: 434-348-4987    Fax: 434-348-4558

Mrs. Katherine Little Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 Market Drive, Emporia, VA 23847 Phone: 434-634-5187

Vicki Lynne Morris, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 303 Market Dr, Emporia, VA 23847 Phone: 434-336-1239    Fax: 434-336-0080

Mr. William Robert Shannonhouse Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 Market Drive, Emporia, VA 23847 Phone: 434-634-5187

Dr. Amanda Lewis Lipscomb, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 303 Market Dr, Emporia, VA 23847 Phone: 434-336-1239    Fax: 434-336-0080

Courtney Cropper, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 E Cloverleaf Dr, Emporia, VA 23847 Phone: 434-634-5187    Fax: 434-634-6499

Mrs. Tracy Barnes Nicholson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 306a Weaver Ave, Emporia, VA 23847 Phone: 434-348-4987    Fax: 434-348-4558

News Archive

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

A new study published on the preprint server bioRxiv* in September 2020 reports on a Moloney murine leukemia virus (MLV) platform that produces VLPs expressing the important spike antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Study investigates effects of glucose-lowering drug in preventing damage to the kidneys

New research presented at the annual meeting of the European Association for the Study of Diabetes and published simultaneously in The Lancet Diabetes & Endocrinology shows how the glucose-lowering drug lixisenatide can slow or prevent damage to the kidneys in macro-albuminuric patients with type 2 diabetes mellitus and cardiovascular disease.

ACT Biotech reports positive interim data from Telatinib Phase 2 trial for advanced gastric cancer

ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.

Late-life depression could become major risk factor for developing Alzheimer's

Many people develop depression in the latest stages of life, but until now doctors had no idea that it could point to a build up of a naturally occurring protein in the brain called beta-amyloid, a hallmark of Alzheimer's disease.

Read more Medical News

› Verified 5 days ago